2107 studies found for:    Open Studies | "Drug Therapy"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Drug Therapy"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Evaluation of Predictive Risk Factors of Chemotherapy-induced Nausea and Vomiting
Conditions: Chemotherapy-induced Nausea and Vomiting;   Moderate Emetogenic Chemotherapy
Intervention:
2 Recruiting Phase 3 Safety and Efficacy Study of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Highly Emetogenic Chemotherapy
Condition: Chemotherapy-induced Nausea and Vomiting
Interventions: Drug: Rolapitant;   Drug: Granisetron;   Drug: dexamethasone
3 Recruiting Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer
Conditions: Locally Advanced Malignant Neoplasm;   Oral Cancer;   Oropharyngeal Carcinoma;   Effects of Chemotherapy
Intervention: Drug: Neo-adjuvant Erbitux-based chemotherapy
4 Unknown  A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by Chemotherapy
Conditions: Breast Cancer;   Chemotherapy;   Neutropenia
Intervention: Other: EW02
5 Unknown  Effect of Enteral Nutrition Rich in Eicosapentaenoic Acid (EPA) on Patients Receiving Chemotherapy for GI Tumor
Conditions: Gastric Cancer;   Colorectal Cancer;   Chemotherapy
Interventions: Drug: Nutriall;   Drug: LDEPA;   Drug: Placebo;   Drug: HDEPA;   Drug: Chemotherapy
6 Unknown  Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer
Conditions: Chemotherapy;   Breast Cancer, Metastatic
Intervention: Drug: Cyclophosphamide, Capecitabine, Methotrexate, Celecoxib, Pamidronate (or Zoledronate)
7 Recruiting An N-of-1 Study of Homeopathic Treatment of Fatigue in Patients Receiving Chemotherapy
Conditions: Fatigue;   Effects of Chemotherapy
Interventions: Other: Homeopathic medicine;   Other: Unmedicated lactose/sucrose globule
8 Recruiting Observational Studies of the Application of Bevacizumab in HER2-negative Breast Cancer Neoadjuvant Chemotherapy
Conditions: Breast Cancer;   Bevacizumab;   Neoadjuvant Chemotherapy;   Molecular Targeted Therapy
Intervention: Drug: bevacizumab
9 Recruiting Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cm
Conditions: Breast Cancer;   Chemotherapy
Interventions: Drug: Taxotere , Epirubicin;   Drug: E-HDFL,EP,TE,N-HDFL,NP,T-HDFL,TP
10 Recruiting Nutrition Intervention During Chemotherapy
Condition: Cancer Patients Receiving Platinum-based Chemotherapy
Intervention: Dietary Supplement: Daily intake for 12 weeks
11 Recruiting Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Conditions: Central Nervous System Tumor, Pediatric;   Chemotherapy-induced Nausea and Vomiting;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Procedure: Real Acupressure Band;   Procedure: Placebo Acupressure Band
12 Recruiting Pilot Study of Olanzapine and Aprepitant to Prevent Nausea and Vomiting in Children Receiving Chemotherapy
Condition: Chemotherapy Induced Nausea and Vomiting
Interventions: Drug: Olanzapine;   Drug: Aprepitant
13 Recruiting LYmphadenectomy After NeoAdjuvant Chemotherapy
Condition: Advanced Ovarian Cancer (Stage III or IV) After Neoadjuvant Chemotherapy
Intervention: Procedure: Systematic pelvic and aortic lymphadenectomy
14 Recruiting Characterization and Treatment of Chemotherapy Neuropathy
Condition: Chemotherapy-induced Neuropathy
Interventions: Procedure: Photon stimulation;   Procedure: Placebo treatment
15 Recruiting Impact of a Telephonic Monitoring During Inter-treatment Intervals on Emotional State, Quality of Life and Toxicities, on Neo Adjuvant or Adjuvant Chemotherapy-treated Patients
Conditions: Non-metastatic Patients With Breast Cancer;   Non-metastatic Patients With Colon Cancer;   Non-metastatic Patients With Rectal Cancer;   Patients Undergoing Adjuvant Chemotherapy
Intervention: Other: Clinical and psychosocial phone calls
16 Recruiting Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
Conditions: Platinum Sensitive;   BRCA Mutated;   Relapsed Ovarian Cancer;   Following Complete or Partial Response to Platinum Based Chemotherapy
Interventions: Drug: Olaparib 300mg tablets;   Drug: Placebo to match olaparib 300mg
17 Recruiting Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in CINV (Chemotherapy-induced Nausea and Vomiting) Associated With the Administration of MEC (Moderately Emetogenic Chemotherapy)
Condition: Chemotherapy-induced Acute or Delayed Nausea and Vomiting (CINV)
Interventions: Drug: Sancuso patch;   Drug: Kytril inj.+Kytril tab.
18 Not yet recruiting The Role of Adding Concurrent Chemotherapy to IMRT in the Treatment of Stage II Nasopharyngeal Carcinoma
Condition: Effects of Chemotherapy
Interventions: Drug: Concurrent chemotherapy with cisplatin;   Radiation: Intensity modulated radiotherapy
19 Recruiting Olaparib Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
Conditions: Newly Diagnosed;   Advanced Ovarian Cancer;   FIGO Stage III-IV;   BRCA Mutation;   Complete Response;   Partial Response;   First Line Platinum Chemotherapy
Intervention: Drug: Olaparib 300mg tablets
20 Unknown  Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy
Conditions: Chemotherapy-Induced Neutropenia;   Breast Cancer
Intervention: Biological: Maxy-G34

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years